Search results
ZYMUTEST D-Dimer Antigen
Assay proposed for the measurement of D-dimer in research applications.
ZYMUTEST FPA Antigen (Plus Controls)
Assay proposed for the measurement of FPA in research applications.
ZYMUTEST Factor IX Antigen
Assay proposed for the measurement of factor IX antigen in research applications.
ZYMUTEST Factor VII Antigen
Assay proposed for the measurement of factor VII antigen in research applications.
ZYMUTEST Factor X Antigen
Assay proposed for the measurement of factor X antigen in research applications.
ZYMUTEST Fibrinogen Antigen
Assay proposed for the measurement of fibrinogen in research applications.
ZYMUTEST Free Protein S
Diagnosis of protein S deficiencies (congenital, acquired or transitory). • Type I deficiency: Partial deficiency of total and free protein S antigen. • Type II deficiency: Normal total and free protein S antigen, reduced activity. • Type III deficiency: Normal total antigen, decreased activity and free antigen. Assay of protein S in clinical studies.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.